Physician

Abigail L Chua, D.O.

According to 2025 Medicare claims, Abigail Chua, D.O. (NPI: 1821381385) practices neurology in the Scranton--Wilkes-Barre, PA market, with the plurality of this provider's patient population coming from Luzerne, PA. This provider's primary affiliated billing organization is GEISINGER CLINIC (NPI: 1255382784; TIN: 236291113) and primary practice location at 18702-7924. Chua is affiliated with the Keystone ACO (ACO ID: A1552) and HARTFORD HEALTHCARE ACCOUNTABLE CARE ORGANIZATION, INC. (ACO ID: A1749), participating under the MSSP model.

Chua's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 97 traditional Medicare patients, billed 512 HCPCS/CPT codes, and received $30,641 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,726 prescription claims across 193 beneficiaries totaling $863,548 in drug costs, led by Ubrelvy (Ubrogepant). Open Payments data shows 2 records totaling $175. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $3,953 and ending at $30,641. Concurrently, Part D prescription costs have risen steadily, from $6,702 to $863,548. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	18	43	$3,953
2017	56	4,383	$51,324
2018	34	10,771	$80,230
2019	46	10,473	$74,002
2020	20	870	$10,127
2021	69	248	$18,388
2022	96	479	$30,163
2023	94	362	$22,881
2024	97	512	$30,641

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	28	149	$6,702
2016	39	314	$17,112
2017	43	241	$7,542
2018	49	532	$49,539
2019	56	587	$154,282
2020	36	176	$71,355
2021	90	443	$137,091
2022	139	1,214	$535,770
2023	177	1,660	$728,983
2024	193	1,726	$863,548

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	23	25	$111
64615	Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face	26	83	$87
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	72	178	$71
20552	Injection of trigger points, 1-2 muscles	22	36	$18
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	54	67	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ubrelvy	Ubrogepant	160	3,859	$197,915
Emgality Pen	Galcanezumab-Gnlm	212	7,781	$182,688
Nurtec Odt	Rimegepant Sulfate	89	2,292	$133,608
Qulipta	Atogepant	53	1,960	$72,091
Aimovig Autoinjector	Erenumab-Aooe	56	2,604	$63,054

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$175	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Abigail L. Chua, D.O.?

Tedicare shows public-source Medicare data for Abigail L. Chua, D.O. (NPI 1821381385), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abigail L. Chua, D.O. have ACO affiliation data?

Abigail L. Chua, D.O. is shown with ACO affiliation data for Keystone ACO (MSSP, ACO ID A1552) and HARTFORD HEALTHCARE ACCOUNTABLE CARE ORGANIZATION, INC. (MSSP, ACO ID A1749).

What billing organization is linked to Abigail L. Chua, D.O.?

Abigail L. Chua, D.O. is linked to GEISINGER CLINIC (billing NPI 1255382784) in the available physician profile data.

Does Abigail L. Chua, D.O. have Open Payments data?

Abigail L. Chua, D.O. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.